Steroid Dosing Regimen for Facial Palsy
For Bell's palsy, prescribe oral prednisolone 50 mg daily for 10 days OR prednisone 60 mg daily for 5 days followed by a 5-day taper, but only when initiated within 72 hours of symptom onset. 1, 2, 3
Timing of Treatment
- Steroids must be initiated within 72 hours of symptom onset to be effective 1, 2, 3
- Clinical trials demonstrating steroid efficacy specifically enrolled patients within this 72-hour window 1
- Starting steroid treatment beyond the 72-hour window provides minimal benefit while exposing patients to medication risks 1
Evidence for Effectiveness
- Strong evidence supports early corticosteroid use, with 83% recovery at 3 months with prednisolone vs 63.6% with placebo 3
- Long-term outcomes show 94.4% recovery at 9 months with prednisolone vs 81.6% with placebo 3
- Early treatment aims to reduce inflammation of the facial nerve before permanent damage occurs 1
Dosing Options
Preferred regimen options:
Important considerations:
Special Populations
Children
- Children have better prognosis with higher rates of spontaneous recovery than adults 1, 3
- Evidence for steroid use in children is less conclusive 3, 5
- A randomized trial showed that at 1 month, recovery rates were 49% with prednisolone vs 57% with placebo 5
- By 6 months, recovery rates were 99% with prednisolone vs 93% with placebo 5
Pregnant Women
- Treatment should be administered with careful assessment of benefits and risks 1, 3
- The same dosing regimen applies, but requires individualized risk-benefit assessment 3
Additional Management
- Eye protection is essential for patients with impaired eye closure to prevent corneal damage 1, 3
- Implement lubricating ophthalmic drops for daytime protection 1
- Use ophthalmic ointments for nighttime protection 1
- Consider moisture chambers, eye patching/taping, and sunglasses as appropriate 1
Common Pitfalls
- Delaying treatment beyond 72 hours significantly reduces effectiveness 1, 2
- Using antiviral therapy alone is ineffective and not recommended 1, 2, 3
- Failing to provide adequate eye protection for patients with impaired eye closure 1, 3
- Not referring patients with incomplete recovery after 3 months for specialist evaluation 1, 3